Using ‘Surfaceomics’ as a Jumping Point, a Case is Made for Clinical Lab Growth
Arun Wiita from USCF details his lab’s work using mass spectrometry
Already a member? Log in here
Diagnostic Testing and Emerging Technologies
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
Diagnostics Pipeline: Cizzle Bio Introduces Test for Earlier Lung Cancer Detection
The CIZ1B biomarker blood-based assay has 95% sensitivity for detecting earliest stage of the cancer
Already a member? Log in here
Generative AI Struggles with Clinical Reasoning
Research shows that large language models lack reasoning skills required for clinical decision-making
Already a member? Log in here
GNPC identifies subset of proteins elevated across Alzheimer’s and Parkinson’s
Consortium hosts large proteomics dataset for neurodegenerative diseases
Already a member? Log in here
Quest Introduces Myeloma Test That Eliminates the Need for Bone Marrow Biopsies
The flow cytometry assay costs a fraction of traditional invasive bone marrow testing
Already a member? Log in here
ClearNote Health Launches Early Detection Test for Pancreatic Cancer
The test offers a 76 percent sensitivity to detection of stage 1 and stage 2 pancreatic cancers
Already a member? Log in here
Turning Physics into a Diagnostic Signal for Bladder Cancer
A physics-based urine test shows early promise in detecting bladder cancer recurrence without invasive procedures
Already a member? Log in here
Diagnostics Pipeline: NeuroQure Launches Test for Early Autism Diagnosis
The skin-based test can be used on children as young as two days old
Already a member? Log in here
How Labs Can Lead in Early Detection of Infectious Diseases
Smarter operations, automation, and collaboration can strengthen laboratories’ role in early detection
Already a member? Log in here
AI-Designed Molecular Sensors Could Transform Early Cancer Detection
Advances could signal changes for clinical laboratories and at-home testing
Already a member? Log in here
Rise of Capillary Electrophoresis in the Clinical Laboratory
The technology has moved from niche to practical for routine diagnostics
Already a member? Log in here
Diagnostics Pipeline: MyOme and Artera Launch New Tests for Prostate Cancer Risk
The two assays identify threats prior to prostate cancer being diagnosed and after it has undergone extensive treatment, respectively
Already a member? Log in here
Lab Directors Should Follow cfDNA Testing Progress in Ongoing Study
AMP Annual Meeting attendees showed strong interest in the blood test
Already a member? Log in here
